Abstract: The present invention relates to a method for modifying release of a therapeutically active agent from an elastomeric matrix, comprising providing a core comprising an elastomeric matrix and a therapeutically active agent; dipping the core to a coating solution of an elastomer, wherein the elastomer comprises 20-35 wt-% of a filler, calculated from the total amount of filler and elastomer; curing the dipped core to provide a coated core. In this method the dipping is provided as a continuous process by pulling the core through the coating solution, using a pulling speed suitable for providing a coating thickness of ?-IOO the filler is selected from silica, titanium dioxide, barium sulphate, carbon and mixtures thereof; the elastomer comprised in the core and the elastomer comprised in the coating solution are independently selected from poly(dimethyl) siloxanes, polyethylene vinyl acetates (EVAs), polyurethanes (PUs), polyhydroxyethyl methacrylates (PHEMAs) and polymethyl methacrylates (PMMAs).

Abstract: Disclosed is an intrauterine system (100, 300, 400, 500, 600) comprising a frame (102, 302, 402, 502, 602), a removal thread (218, 326, 436, 626) and at least one pharmaceutically active agent. The frame has a first end (104, 304, 404, 504, 604), a second end (106, 306, 406, 506, 606) and a length L. The first end of the frame comprises a first locking part (108, 308, 408, 508, 608) and the second end of the frame comprises a second locking part (110, 310, 410, 510, 610), the first locking part and the second locking part being arranged to form a lock (202, 312, 432). The removal thread is attached to the first end of the frame. The removal thread is configured to guide the first locking part to the second locking part. Further, disclosed is a kit comprising the aforementioned intrauterine system and an inserter.

Abstract: There are disclosed processes for destructing a toxic chemical including the steps of mixing the toxic chemical with a liquid phase formed by an aqueous mixture of water and an ionic liquid or molten salt which is miscible with water, the ionic liquid or molten salt comprising a tertiary amine group or quaternary ammonium group; and contacting the toxic chemical in the liquid phase with the ionic liquid or molten salt so as to decompose the toxic chemical.

Abstract: The present invention relates to a method for modifying release of a therapeutically active agent from an elastomeric matrix, comprising providing a core comprising an elastomeric matrix and a therapeutically active agent; dipping the core to a coating solution of an elastomer, wherein the elastomer comprises 20-35 wt-% of a filler, calculated from the total amount of filler and elastomer; curing the dipped core to provide a coated core. In this method the dipping is provided as a continuous process by pulling the core through the coating solution, using a pulling speed suitable for providing a coating thickness of ?-IOO the filler is selected from silica, titanium dioxide, barium sulphate, carbon and mixtures thereof; the elastomer comprised in the core and the elastomer comprised in the coating solution are independently selected from poly(dimethyl) siloxanes, polyethylene vinyl acetates (EVAs), polyurethanes (PUs), polyhydroxyethyl methacrylates (PHEMAs) and polymethyl methacrylates (PMMAs).

Abstract: A method of destructing a toxic chemical, comprising the steps of mixing said toxic chemical with a liquid phase formed by an aqueous mixture of water and an ionic liquid or molten salt which is miscible with water, said ionic liquid or molten salt comprising a tertiary amine group or quaternary ammonium group; and contacting said toxic chemical in said liquid phase with said ionic liquid or molten salt so as to decompose said toxic chemical. The ionic liquid or molten salt comprises a tertiary amine group or quaternary ammonium group. The dispersion or solution further contains at least one oxidizing agent and a donor of hydrogen bonds. Decontamination of contaminated surfaces and decomposition of toxic substances are achieved by using environmentally friendly, non-toxic solvents and reactants which yields reaction products which are substantially non-harmful or even non-toxic.

Abstract: Biodegradable polymers formed from biodegradable polyester-based prepolymers, to which ring-structured anhydrides which have different hydrophobicities have been connected, and which are either coupled to form linear thermoplastic polyester anhydrides or cross-linked to form network-structured polyester anhydrides. It is possible to adjust widely the degradation rate and mechanism of the polymers and thus they can be used, for example, in the controlled dosing of pharmaceutical ingredients, for tissue technological applications, in surgery and in bioactive composites.

Abstract: The present invention relates to new biodegradable polymers. These polymers comprise biodegradable polyester-based prepolymers, to which ring-structured anhydrides which have different hydrophobicities have been connected, and which are either coupled to form linear thermoplastic polyester anhydrides or cross-linked to form network-structured polyester anhydrides. It is possible to adjust widely the degradation rate and mechanism of the polymers according to the present invention, and thus they can be used, for example, in the controlled dosing of pharmaceutical ingredients, for tissue technological applications, in surgery and in bioactive composites.